Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13626
CALL
Diana Shipping
DSX
$356M
| $9.02K | ﹤0.01% |
4,600
-17,000
| -79% | -$36.2K |
2021 Q2
14 quarters
|
|
|
MILN
13627
CALL
Global X Millennial Consumer ETF
MILN
$87.6M
| $8.99K | ﹤0.01% |
+200
| New | +$8.93K |
2024 Q4
0 quarters
|
|
13628
PUT
Neuropace
NPCE
$454M
| $8.95K | ﹤0.01% |
800
+700
| +700% | +$6.09K |
2024 Q1
3 quarters
|
|
|
YDKG
13629
Yueda Digital Holding
YDKG
$5.14M
| $8.94K | ﹤0.01% |
+196
| New | +$8.89K |
2024 Q4
0 quarters
|
|
13630
CALL
Qiagen
QGEN
$9.46B
| $8.91K | ﹤0.01% |
194
-37,820
| -99% | -$1.69M |
2018 Q2
26 quarters
|
|
13631
CALL
Destination XL Group
DXLG
$22.1M
| $8.88K | ﹤0.01% |
3,300
-17,600
| -84% | -$47.3K |
2024 Q2
2 quarters
|
|
|
ORLA
13632
PUT
DELISTED
Orla Mining
ORLA
| $8.86K | ﹤0.01% |
1,600
+1,500
| +1,500% | +$7.24K |
2022 Q4
8 quarters
|
|
13633
CALL
MoneyHero
MNY
$29.5M
| $8.85K | ﹤0.01% |
7,900
-19,500
| -71% | -$22.1K |
2023 Q4
4 quarters
|
|
13634
CALL
LiveOne
LVO
$36.3M
| $8.82K | ﹤0.01% |
600
-1,990
| -77% | -$17.4K |
2022 Q2
10 quarters
|
|
|
ADAP
13635
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
| $8.78K | ﹤0.01% |
16,300
+10,500
| +181% | +$7.65K |
2024 Q1
3 quarters
|
|
13636
PUT
HBT Financial
HBT
$1.32B
| $8.76K | ﹤0.01% |
400
-100
| -20% | -$2.28K |
2023 Q4
4 quarters
|
|
13637
CALL
Dianthus Therapeutics
DNTH
$4.92B
| $8.72K | ﹤0.01% |
400
| – | – |
2024 Q3
1 quarter
|
|
13638
CALL
IBEX
IBEX
$575M
| $8.6K | ﹤0.01% |
400
-500
| -56% | -$9.83K |
2024 Q3
1 quarter
|
|
13639
PUT
Champions Oncology
CSBR
$69.2M
| $8.57K | ﹤0.01% |
+1,000
| New | +$5.03K |
2024 Q4
0 quarters
|
|
13640
PUT
Fusion Fuel Green
HTOO
$15.8M
| $8.56K | ﹤0.01% |
434
+183
| +73% | +$3.32K |
2024 Q1
3 quarters
|
|
13641
Algonquin Power & Utilities
AQN
$3.9B
| $8.53K | ﹤0.01% |
1,917
| – | – |
2021 Q2
14 quarters
|
|
|
BBT
13642
PUT
Beacon Financial Corp
BBT
$2.36B
| $8.53K | ﹤0.01% |
300
+100
| +50% | +$2.88K |
2024 Q1
3 quarters
|
|
|
TSVT
13643
PUT
DELISTED
2seventy bio
TSVT
| $8.53K | ﹤0.01% |
2,900
-1,900
| -40% | -$7.79K |
2022 Q4
8 quarters
|
|
13644
CALL
CEMIG Preferred Shares
CIG
$6.81B
| $8.5K | ﹤0.01% |
4,800
-10,440
| -69% | -$20.3K |
2022 Q4
8 quarters
|
|
13645
PUT
Oramed Pharmaceuticals
ORMP
$189M
| $8.47K | ﹤0.01% |
3,500
+1,400
| +67% | +$3.33K |
2024 Q3
1 quarter
|
|
13646
CALL
Alpha Pro Tech
APT
$58.7M
| $8.46K | ﹤0.01% |
1,600
-21,200
| -93% | -$116K |
2020 Q1
19 quarters
|
|
13647
PUT
Ooma
OOMA
$580M
| $8.44K | ﹤0.01% |
600
+500
| +500% | +$6.67K |
2024 Q1
3 quarters
|
|
13648
PUT
nLIGHT
LASR
$2.28B
| $8.39K | ﹤0.01% |
800
+700
| +700% | +$7.79K |
2024 Q3
1 quarter
|
|
13649
CALL
RPC Inc
RES
$1.35B
| $8.32K | ﹤0.01% |
1,400
-1,300
| -48% | -$8.06K |
2022 Q4
8 quarters
|
|
|
SBDS
13650
DELISTED
Solo Brands Inc
SBDS
| $8.25K | ﹤0.01% |
181
-107
| -37% | -$5.3K |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.